- Home
- SNDX vs OMI Comparison
SNDX vs OMI Comparison
Compare SNDX & OMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- OMI
- Stock Information
- Founded
- SNDX 2005
- OMI 1882
- Country
- SNDX United States
- OMI United States
- Employees
- SNDX N/A
- OMI N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- OMI Medical Specialities
- Sector
- SNDX Health Care
- OMI Health Care
- Exchange
- SNDX Nasdaq
- OMI Nasdaq
- Market Cap
- SNDX 1.1B
- OMI 1.0B
- IPO Year
- SNDX 2016
- OMI N/A
- Fundamental
- Price
- SNDX $13.08
- OMI $14.57
- Analyst Decision
- SNDX Strong Buy
- OMI Buy
- Analyst Count
- SNDX 10
- OMI 6
- Target Price
- SNDX $36.20
- OMI $19.58
- AVG Volume (30 Days)
- SNDX 2.6M
- OMI 681.0K
- Earning Date
- SNDX 02-25-2025
- OMI 02-18-2025
- Dividend Yield
- SNDX N/A
- OMI N/A
- EPS Growth
- SNDX N/A
- OMI N/A
- EPS
- SNDX N/A
- OMI N/A
- Revenue
- SNDX $16,000,000.00
- OMI $10,660,960,000.00
- Revenue This Year
- SNDX N/A
- OMI $4.93
- Revenue Next Year
- SNDX $14.15
- OMI $3.75
- P/E Ratio
- SNDX N/A
- OMI N/A
- Revenue Growth
- SNDX N/A
- OMI 4.22
- 52 Week Low
- SNDX $12.06
- OMI $11.42
- 52 Week High
- SNDX $25.34
- OMI $28.35
- Technical
- Relative Strength Index (RSI)
- SNDX 41.29
- OMI 59.70
- Support Level
- SNDX $12.40
- OMI $12.56
- Resistance Level
- SNDX $13.16
- OMI $15.53
- Average True Range (ATR)
- SNDX 0.65
- OMI 0.67
- MACD
- SNDX 0.10
- OMI 0.17
- Stochastic Oscillator
- SNDX 39.38
- OMI 69.81
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.